The NIH is offering a limited-competition grant to support the Pediatric Brain Tumor Consortium (PBTC) in continuing its work of improving treatments for primary brain tumors in children. This grant aims to translate innovative therapies from the laboratory to early phase clinical testing, focusing on high-risk pediatric brain tumor histotypes. The PBTC plays a crucial role in addressing the high mortality rates and functional impediments associated with these tumors. Researchers can apply for this grant to contribute to the advancement of pediatric brain tumor research before the closing date on Sep 16, 2013.
Opportunity ID: 236597
General Information
| Document Type:: | Grants Notice |
| Funding Opportunity Number:: | RFA-CA-13-502 |
| Funding Opportunity Title:: | Limited Competition: Pediatric Brain Tumor Consortium (UM1) |
| Opportunity Category:: | Discretionary |
| Opportunity Category Explanation:: | |
| Funding Instrument Type:: | |
| Category of Funding Activity:: | Education |
| Category Explanation:: | |
| Expected Number of Awards:: | |
| Assistance Listings Number(s):: | 93.395 — Cancer Treatment Research |
| Cost Sharing or Matching Requirement:: | No |
| Version:: | Synopsis 1 |
| Posted Date:: | Jun 19, 2013 |
| Last Updated Date:: | |
| Original Closing Date for Applications:: | Sep 16, 2013 |
| Current Closing Date for Applications:: | Sep 16, 2013 |
| Archive Date:: | Oct 17, 2013 |
| Estimated Total Program Funding:: | $ 2,590,000 |
| Award Ceiling:: | $2,590,000 |
| Award Floor:: | $ |
Eligibility
| Eligible Applicants:: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility:: | Other Eligible Applicants include the following: Only the current awardees of Pediatric Brain Tumor Consortium funded under RFA-CA-08-026 are eligible to apply under this Limited Competition FOA. Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. |
Additional Information
| Agency Name:: | National Institutes of Health |
| Description:: | This Funding Opportunity Announcement (FOA) is intended to continue support for the Pediatric Brain Tumor Consortium (PBTC). This limited-competition FOA solicits a single application from the current PBTC awardee. The PBTC was conceived as a dedicated clinical trials organization able to translate innovative therapies from the laboratory to early phase clinical testing so that treatment for primary brain tumors in children can be improved. The importance of the PBTC is highlighted by the continuing high mortality rate among some common brain tumor histotypes occurring in children [e.g., diffuse intrinsic pontine gliomas (DIPG), malignant supratentorial gliomas, and biologically high-risk medulloblastomas and ependymomas] and the functional impediments apparent in a large proportion of children surviving current therapies. The PBTC is designed to fill a unique niche in the NIH pediatric brain tumor research portfolio through its ability to translate multiple innovative therapies from the laboratory to early phase clinical testing. |
| Link to Additional Information:: | |
| Grantor Contact Information:: | If you have difficulty accessing the full announcement electronically, please contact: |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Synopsis 1 |
Package Status
Package No: 1